English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 24 January 2020, 12:00 HKT/SGT
Share:
New Disinfectant Stops Spread of Virus, Including Coronavirus Strain from China

SYDNEY, AU, Jan 24, 2020 - (ACN Newswire) - Australian researcher Steven Kritzler says his Evocide Extra disinfectant is able to stop the spread of virus, as in the present outbreak in Wuhan City, China. This new strain of Coronavirus is a SARS-like virus that has caused hundreds of infections in China, and has spread to Thailand, Japan and South Korea.

Steven Kritzler of Novapharm Research (Aus) Pty. Ltd.

"Both the Wuhan virus, known as 2019-nCoV, and SARS belong to the family of viruses known as Coronaviridae, which can be deactivated by many materials, such as Evocide Extra," says Kritzler, who is based at Novapharm Research near Sydney, and is a committee member of the Australian Therapeutic Goods Administration (TGA).

Kritzler garnered attention at the Symposium on Advanced Infection Control in November when his Evocide Extra disinfectant formulation was presented. "Coronavirus is a type of enveloped virus -- a virus that develops viruses. My formulation can deactivate any virus, including enveloped and non-enveloped viruses."

"Coronavirus is microscopic, hence face masks alone cannot effectively prevent spreading the virus. I suggest that the best way to protect from spreading the virus is to wash your hands regularly, for example when you touch the door handle. And remember to use the disinfectants in time," says Kritzler.

Southern Cross, another formulation by Kritzler, are eco-friendly skin and hard surface disinfectant paper wipes that can deactivate viruses such as HIV (human immunodeficiency virus), hand-foot-mouth (EV71), influenza A (H1N1) and measles, and like Evocide can kill 99.999% of bacterial pathogens including super bacteria.

The Chinese Spring Festival holiday begins later this week, increasing the risk of spread of the new virus. The holiday period typically sees hundreds of millions of Chinese traveling throughout the country and overseas.

Contact: Kenny Kang, kz@fromau.com
Southern Cross Biotechnology Pty Ltd.

Topic: Press release summary Sectors: Environment, ESG, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Telangana Rising 2047 Vision Document to Be Released on Dec 8-9, 2025, at Global Summit in Bharat Future City  
Dec 6, 2025 07:00 HKT/SGT
Wear the Speed, Live the Convenience: Tappy Technologies Powers the Launch of High Performance Payment Bands in Collaboration with First Abu Dhabi Bank and Mastercard  
Dec 5, 2025 18:53 HKT/SGT
Leapfrog Acquisition Corp Announces Pricing of $125,000,000 Initial Public Offering  
Dec 5, 2025 17:50 HKT/SGT
Bank Indonesia Unveils Five-Point Strategy to Boost Indonesia's Economic Resilience  
Dec 5, 2025 16:00 HKT/SGT
Business of IP Asia (BIP Asia) Forum and Entrepreneur Day open today  
Dec 5, 2025 15:41 HKT/SGT
Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants  
Dec 5, 2025 15:00 HKT/SGT
Doubleview Extends High-Grade Domains at Hat: H099 Returns 438m of 0.40% CuEq Including 52m of 1.02% CuEq, Expanding Mineralization Envelope Around Conceptual Pit Vertically and Laterally  
Dec 4, 2025 21:59 HKT/SGT
CaoCao Unveils '100 Cities, 100 Billion in 10 Years' Robotaxi Strategy, Officially Launches World's First 'Green Intelligent Mobility Hub'  
Dec 4, 2025 21:00 HKT/SGT
The Gourmet's Guide: Using Your TravelKon eSIM to Hunt for Japan's Best Ramen, Sushi, and Street Food  
Dec 4, 2025 17:45 HKT/SGT
Spritzer Celebrates Global and Regional Brand Excellence 2025  
Dec 4, 2025 12:45 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575